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Abstract
Background—Factors underlying a possible excess of amyotrophic lateral sclerosis (ALS) 
among military veterans remain unidentified. Limitations of previous studies on this topic include 
reliance on ALS mortality as a surrogate for ALS incidence, low statistical power, and sparse 
information on military-related factors.
Objectives—We evaluated associations between military-related factors and ALS using data 
from a case-control study of U.S. military veterans.
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Methods—From 2005 to 2010, we identified medical record-confirmed ALS cases via the 
National Registry of Veterans with ALS and controls via the Veterans Benefits Administration’s 
Beneficiary Identification and Records Locator System database. In total, we enrolled 621 cases 
and 958 frequency-matched controls in the Genes and Environmental Exposures in Veterans with 
Amyotrophic Lateral Sclerosis study. We collected information on military service and 
deployments and 39 related exposures. We used unconditional logistic regression models to 
estimate odds ratios (ORs) and 95% confidence intervals (CIs). We used inverse probability 
weighting to adjust for potential bias from confounding, missing covariate data, and selection 
arising from a case group that disproportionately included long-term survivors and a control group 
that may or may not differ from U.S. military veterans at large.
Results—The odds of ALS did not differ for veterans of the Air Force, Army, Marines, and 
Navy. We found higher odds of ALS for veterans whose longest deployment was World War II or 
the Korean War and a positive trend with total years of all deployments (OR = 1.27; 95% CI: 1.06, 
1.52). ALS was positively associated with exposure to herbicides for military purposes, 
nasopharyngeal radium, personal pesticides, exhaust from heaters or generators, high-intensity 
radar waves, contaminated food, explosions within one mile, herbicides in the field, mixing and 
application of burning agents, burning agents in the field, and Agent Orange in the field, with ORs 
between 1.50 and 7.75.
Conclusions—Although our results need confirmation, they are potentially important given the 
large number of U.S. military veterans, and they provide clues to potential factors underlying the 
apparent increase of ALS in veteran populations.
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1. Introduction
Amyotrophic lateral sclerosis (ALS) is a debilitating neurodegenerative disease involving 
motor neuron loss in the central nervous system (Mitchell and Borasio, 2007). A possible 
association between military-related factors and ALS was first suggested in connection with 
the 1990–1991 Persian Gulf War (hereafter “Gulf War”). Five of seven previously published 
studies reported an increased rate of ALS incidence, hospitalization, or mortality among 
veterans deployed to the Gulf War compared to veterans deployed elsewhere (Barth et al., 
2009; Coffman et al., 2005; Haley, 2003; Horner et al., 2008; Horner et al., 2003; Kang and 
Bullman, 2001; Smith et al., 2000). Another study found a higher ALS mortality rate among 
men who reported military service than men who did not (Weisskopf et al., 2005). This 
result was recently confirmed by studies in the U.S. (Weisskopf et al., 2015), Denmark 
(Seals et al., 2015), and Scotland (Bergman et al., 2015). Most of these studies, and 22 
others on this topic that we recently reviewed (Beard and Kamel, 2015), were limited by 
reliance on ALS mortality as a surrogate for ALS incidence, low statistical power, and 
sparse information on military-related factors. In addition, two-thirds of these studies did not 
include information on specific military exposures. Thus, the factors underlying the possibly 
increased rate of ALS among veterans remain unidentified.
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The Genes and Environmental Exposures in Veterans with Amyotrophic Lateral Sclerosis 
study (GENEVA), conducted from 2005 to 2010, is a case-control study of veterans with 
ALS from the U.S. National Registry of Veterans with ALS (hereafter “Registry”) (Allen et 
al., 2008) and frequency-matched veteran controls identified via U.S. Department of 
Veterans Affairs (VA) databases (Schmidt et al., 2008). To enroll in GENEVA, participants 
had to confirm that they had been members of the U.S. Army, Air Force, Navy, Marine 
Corps, Coast Guard, activated Reserves or National Guard at some point in time (Beard, 
2015). They did not have to have been deployed to war. We evaluated associations between 
ALS and several aspects of military service and deployments as well as 39 related exposures 
among veterans in GENEVA.
2. Materials and methods
2.1. Study population and case definition
Enrollment of cases first in the Registry, then in GENEVA, was described previously (Allen 
et al., 2008; Schmidt et al., 2008). Briefly, the Registry was started because of the possible 
connection between ALS and deployment to the Gulf War (Allen et al., 2008; Kasarskis et 
al., 2004; Schmidt et al., 2008). Potential cases were recruited for the Registry from 2003 to 
2007 (i.e., the year Haley (2003) and Horner (2003) were published to when funding 
expired). Recruitment strategies included publicizing the Registry and searches of national 
VA databases for patients with International Classification of Diseases, 9th Revision (World 
Health Organization, 1977), codes of the form 335.2X (motor neuron diseases) (Allen et al., 
2008). In total, 7,116 potential cases were identified, 4,626 completed a telephone screening 
(Beard, 2015), and 2,600 reported a past diagnosis (Allen et al., 2008). Of these, 2,400 
consented to join, 2,265 provided medical records for review by ALS specialist neurologists, 
and 2,122 had a diagnosis of ALS or a related motor neuron disease confirmed according to 
the Revised El Escorial Criteria (Allen et al., 2008; Brooks et al., 2000). These 2,122 veteran 
cases were followed via standardized semi-annual telephone interviews until 2009.
Ascertainment of GENEVA cases from those enrolled in the Registry is shown in Figure 1. 
Of 1,856 ALS cases, 1,837 gave permission to be re-contacted for further studies, 1,356 
consented to join the Registry DNA bank, and 847 were able to be contacted regarding 
GENEVA enrollment. Of these, 726 consented to join and 630 were interviewed of which 
621 were included in this analysis because they were not missing covariate data. These cases 
include those with clinically definite, probable, possible, or suspected ALS.
Enrollment of GENEVA controls was described previously (Schmidt et al., 2008). Figure 2 
shows ascertainment of GENEVA controls from an age-stratified random sample of 10,000 
records obtained in June 2005 from the Veterans Benefits Administration’s Beneficiary 
Identification and Records Locator System (BIRLS) database (Schmidt et al., 2008). Of 
8,966 potential controls with addresses available, 4,420 were mailed invitations, 2,728 were 
able to be contacted by telephone, and 1,618 were screened for eligibility. Nine individuals 
not part of the original BIRLS sample contacted GENEVA regarding enrollment and were 
screened for eligibility. In total, 1,536 potential controls were eligible, 1,055 consented to 
join, and 975 controls were interviewed of which 958 were included in this analysis because 
they were not missing covariate data.
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Controls were frequency-matched to cases on diagnosis age (within five years) and use of 
the VA health care system before diagnosis date (cases) or interview date (controls) 
(Schmidt et al., 2008). We matched on age because it is a risk factor for ALS (Mitchell and 
Borasio, 2007). VA health care use served as a surrogate for socioeconomic status, which 
may be related to ALS (Sutedja et al., 2007).
GENEVA was approved by Institutional Review Boards of the Durham VA Medical Center, 
Duke University Medical Center, and the National Institute of Environmental Health 
Sciences; the Institutional Review Board of the University of North Carolina at Chapel Hill 
approved this ancillary study. All participants gave written or oral informed consent before 
enrollment.
2.2. Exposure assessment
For cases, we extracted clinical characteristics from medical records and collected baseline 
(closest to GENEVA enrollment) ALS Functional Rating Scale-Revised (ALSFRS-R) score 
(Cedarbaum et al., 1999) via the Registry semi-annual interviews (Beard, 2015). For cases 
and controls, we used standardized telephone interviews for GENEVA (Beard, 2015) to 
gather information on military service, deployments, and exposures that occurred before 
diagnosis date (cases) or interview date (controls), as well as on potential confounders 
(Beard, 2015; Schmidt et al., 2008). Proxy interviews were necessary for 34 (5%) cases, but 
no controls. More detail regarding interview procedures is provided elsewhere (Schmidt et 
al., 2008).
Self-reported information on military service included branch of longest service (i.e., the 
branch in which the veteran served the longest total time), number of branches, rank, total 
service time, and end of most recent service (Supplementary data, p. S3). Self-reported 
information on deployments to World War II (WWII) and the Korean, Vietnam, and Gulf 
Wars (hereafter “four wars”) as well as operations in nine other locations included ever 
deployment to any war/operation, war/operation of longest deployment (i.e., the war or 
operation to which the veteran was deployed for the longest total time), total time of all 
deployments, and end of most recent deployment (Supplementary data, p. S3). We also had 
self-reported information on ever deployment to any other country; ever receiving imminent 
danger pay, hardship duty, or combat zone tax exclusion benefits for deployment to 17 
foreign countries and/or five sea regions (plus fill-in options); and total time deployed to 
those countries/sea regions (Supplementary data, p. S3).
We had self-reported information on 39 specific military exposures, which we chose by 
adapting the questionnaires used in the Iowa Gulf War study (Doebbeling et al., 2002) and 
the Millennium Cohort Study (Ryan et al., 2007; Smith et al., 2009) for use in GENEVA 
(Beard, 2015; Schmidt et al., 2008). In addition, we added a few questions on exposures that 
were specific to one or more of the four wars (e.g., Agent Orange exposure during the 
Vietnam War). We queried 32 of 39 exposures only in reference to exposure during 
deployment to the four wars, which covered 16–231 cases and 30–338 controls depending 
on the war(s). For the seven non-war-specific exposures, information included ever exposure 
and, for some, a quantification of exposure (e.g., number of shots). For 31 of 32 war-specific 
exposures, we asked participants whether they had ever been exposed, days exposed (Not 
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exposed, ≤ 5, 6–30, > 30), and whether they felt ill after exposure (Not exposed, No, Yes). 
For the other war-specific exposure, total vaccinations, we had self-reported information on 
number of shots.
2.3. Statistical analyses
We identified risk factors for ALS from previous literature to consider as potential 
confounders (Supplementary data, p. S5). We used directed acyclic graphs (Greenland et al., 
1999) to identify minimally sufficient adjustment sets (MSASs) among potential 
confounders (Supplementary data, Figure S.1 and p. S5). When military service factors were 
the explanatory variables of interest, the MSAS was age, sex, and race/ethnicity; when 
military deployments and exposures were of interest, the MSAS was age, sex, race/ethnicity, 
and branch of service. We also adjusted for VA health care use before diagnosis/interview 
date because it was a matching factor (Schmidt et al., 2008). We centered age at 60 years—
the median age among controls—and modeled it with linear and quadratic terms. We used 
categorical variables to model the other covariates as follows: VA health care use (No, Yes), 
race/ethnicity (non-Hispanic White, other), and branch of service (Air Force, Army, 
Marines, Navy, other [e.g., Coast Guard, Reserves]).
We used unconditional logistic regression models to calculate odds ratios (ORs) and 95% 
confidence intervals (CIs) for associations between military-related factors and ALS. We 
calculated three types of stabilized inverse probability weights (hereafter “weights”) (Cole 
and Hernan, 2008; Hernan et al., 2004), a type of propensity score, to adjust for 1) matching 
factors and confounders in the MSASs, 2) potential bias resulting from missing data on 
ALSFRS-R score for 8% of Registry cases, and 3) potential selection bias from studying a 
case group that disproportionately included long-term survivors at GENEVA enrollment and 
a control group that may differ from U.S. military veterans at large (Schmidt et al., 2008; 
Schmidt et al., 2010) (Supplementary data, p. S6). We calculated confounding weights for 
each exposure separately, but used the same weights for missing ALSFRS-R score (cases 
only) and selection for every exposure. We evaluated appropriateness of the weights in our 
analyses using established criteria (Cole and Hernan, 2008) (Supplementary data, p. S11). 
We multiplied the three types of weights to obtain overall stabilized weights and applied 
these to unconditional logistic regression models containing the exposure of interest as the 
only explanatory variable in the same way sampling weights are applied when analyzing 
data from complex survey sampling designs (Cole and Hernan, 2008; Robins et al., 2000). 
We calculated 95% CIs using robust variance estimates because using weights for analysis 
induces within-subject correlation (Hernan et al., 2000). The weighted ORs and 95% CIs 
thus generalize to the population of 1,785 Registry cases who had diagnoses of clinically 
definite, probable, possible, or suspected ALS and no missing data on covariates used to 
calculate the weights, and the population of 9,983 potential controls from the BIRLS 
database who had no missing data on covariates used to calculate the weights.
Nine of 32 war-specific exposures were distinct to a single war only. For these nine 
exposures (two Vietnam and seven Gulf War), our weights were inappropriate because they 
weighted GENEVA cases to represent all Registry cases and weighted GENEVA controls to 
represent all BIRLS potential controls regardless of age or era of service. To mitigate this 
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problem for Vietnam War-specific exposures, we restricted analyses to Registry cases (n = 
302) and BIRLS potential controls (n = 3,793) who were ages 18–25 years during that war. 
The small number of Gulf War veterans in our study precluded a similar approach for 
exposures distinct to that war.
To assess linear exposure-response trends for categorized versions of continuous variables, 
we used within-category medians as scores (Greenland, 2008) and scaled corresponding 
ORs to one unit or interquartile range (IQR) increases in the original continuous variables. 
We used category midpoints, and 50% above the lower bound of the top category, as scores 
when assessing linear trends for days exposed to each of 31 exposures experienced during 
deployment to the four wars and scaled corresponding ORs to 20-day increases. We used 
ordinal scores to assess linear trends for feeling ill after exposure to each of the same 31 
exposures.
We conducted several secondary analyses. We separately analyzed war-specific exposures 
for veterans deployed to the Vietnam War (cases: 64% of those with war-specific data; 
controls: 80%); too few veterans were deployed to other wars to conduct similar analyses for 
them. We conducted analyses within subsets chosen to reduce sample heterogeneity: cases 
who enrolled in GENEVA within two years of diagnosis (40%); cases who had clinically 
definite or probable ALS (74%); or participants who never visited or resided in western 
Pacific regions with high endemic ALS (Mitchell and Borasio, 2007) (cases: 84%; controls: 
80%). To further explore confounding, we augmented models for the confounding weights 
by additionally including highest degree attained, rank, years of service, or war/operation of 
longest deployment one at a time. As alternative ways to control confounding by sex and 
race/ethnicity, we restricted analyses to men (cases: 98%; controls: 93%) or to non-Hispanic 
White men (cases: 90%; controls: 82%). To mitigate potential bias from exposure 
misclassification, we restricted analyses to non-proxy interviews (cases: 95%; controls: 
100%). We recoded the reference date for controls to be 30 months (i.e., the median time 
between diagnosis and interview for cases) earlier because, since cases and controls were 
asked to use their diagnosis and interview dates, respectively, as the reference date (Schmidt 
et al., 2008), controls may have had more time than cases to be exposed. For analyses 
involving the 39 military exposures, we calculated Spearman correlation coefficients to 
identify correlated exposures and then mutually-adjusted exposures whose correlation 
coefficients exceeded 0.2 in absolute value. Finally, we used standard regression methods to 
adjust for potential confounding, but without weighting for potential bias from selection or 
missing baseline ALSFRS-R score. We performed all analyses with SAS version 9.3 (SAS 
Institute Inc., Cary, NC, 2011).
3. Results
Cases and controls were closely matched on age and use of VA health care (Table 1). After 
adjustment for these matching factors, the odds of ALS were lower among women, veterans 
of a race/ethnicity other than non-Hispanic White, and those with more education compared 
to men, non-Hispanic Whites, or those with less education, respectively. Clinical 
characteristics of cases are shown in Table 2.
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In weighted analyses, the odds of ALS did not differ among veterans of the Air Force, Army, 
Marines, and Navy, but ALS was less common among veterans of other branches (e.g., 
Coast Guard, Reserves) and among veterans who had been officers compared to non-officers 
(Table 3). We observed inverse trends between ALS and number of service branches as well 
as years of service and end of most recent service.
ALS was more common among veterans whose longest deployment was to WWII or the 
Korean War, but less common among veterans whose longest deployment was to operations 
other than the four wars, compared to those not deployed (Table 4). We found an inverse 
trend between ALS and end of most recent deployment. ALS was inversely associated with 
ever receiving danger pay and had an inverse trend with cumulative time of receipt of danger 
pay.
Weighted results for ever experiencing specific exposures during service or deployment to 
the four wars are presented in Table 5, whereas weighted results from analyses of exposure-
response trends and feeling ill after exposure are in Supplementary data (Tables S.1-S.2. 
Among exposures experienced any time during service, anthrax vaccination, herbicides used 
for military purposes, nasopharyngeal radium, and pyridostigmine bromide all had ORs for 
ALS of at least 1.50, although none had exposure-response trends. Among exposures 
experienced during deployment to the four wars, ever exposure to exhaust from heaters or 
generators, high-intensity radar waves, explosions within one mile, herbicides in the field, 
mixing and application of burning agents, burning agents in the field, and Agent Orange in 
the field all had ORs for ALS of at least 1.50 and had positive exposure-response trends. 
Moreover, all seven of these exposures had higher odds of ALS among those who felt ill 
after exposure compared to those not exposed, although some of the exposures (high-
intensity radar waves, herbicides in the field, and mixing and application of burning agents) 
had fewer than five cases or controls who felt ill after exposure. In addition, total number of 
preventive vaccinations received, heat illness, and microwave radiation had positive 
exposure-response trends. Odds of ALS were higher among those who felt ill after exposure 
to pesticides on clothing or bedding and riot control substances in the field compared to 
those not exposed; however, fewer than five cases felt ill after exposure to riot control 
substances in the field.
Results from sub-analyses restricted to Vietnam War-deployed veterans were generally 
similar (Supplementary data, Tables S.3-S.6), although the OR for exposure to pesticides on 
clothing or bedding was greater than 1.50 (OR = 1.83; 95% CI: 0.99, 3.40). Results were 
also similar in analyses of restricted subsets designed to reduce sample heterogeneity, to 
control confounding by sex and race/ethnicity, or to mitigate potential bias from exposure 
misclassification (not shown). Augmenting models for the confounding weights by 
additionally including highest degree attained or rank one at a time gave similar results. 
Many of the inverse associations we observed between ALS and military service and 
deployment factors (e.g., rank, ever receiving danger pay, cumulative time of receipt of 
danger pay) attenuated when we additionally included years of service in the models for the 
confounding weights, but the most notable change was a positive trend between ALS and 
total time of all deployments (≤ 1 year: OR = 0.96; 95% CI: 0.69, 1.35; > 1–2 years: OR = 
0.79; 95% CI: 0.47, 1.35; > 2–3 years: OR = 2.14; 95% CI: 0.90, 5.12; > 3–5 years: OR = 
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2.99; 95% CI: 0.80, 11.09; > 5 years: OR = 2.93; 95% CI: 0.65, 13.30; trend for a one-year 
increase: OR = 1.27; 95% CI: 1.06, 1.52). Additionally including war/operation of longest 
deployment in models for the confounding weights increased ORs above 1.50 for exposure 
to personal pesticides (OR = 1.61; 95% CI: 0.91, 2.85) and contaminated food (OR = 2.05; 
95% CI: 0.90, 4.69). Recoding the reference date for controls to be 30 months (i.e., the 
median time between diagnosis and interview for cases) earlier gave similar results (not 
shown). Most correlation coefficients for associations between exposures were less than 0.2 
in absolute value; mutual adjustment of more strongly correlated exposures left results 
unchanged (not shown). Finally, results using standard regression methods to adjust for 
potential confounding, but without weighting for potential bias from selection or missing 
baseline ALSFRS-R score, were generally similar qualitatively with a few exceptions 
(Supplementary data, Tables S.1-S.9, “Adjusted” columns).
4. Discussion
In contrast to prior etiological studies of ALS among military veterans which relied upon 
death certificate diagnoses, GENEVA obtained medical record-confirmed diagnoses of ALS. 
In addition, GENEVA has a relatively large sample size compared to prior studies, although 
the number of exposed cases available for analyses of some exposures in the current 
analysis, particularly those specific to the Gulf War, was small. This study collected 
extensive information on military service and deployment factors as well as on 39 specific 
exposures. Our results were similar in sub-analyses that created a more homogeneous 
sample or that attempted to reduce potential biases. Finally, we used inverse probability 
weighting to explore and control potential bias from confounding, missing baseline 
ALSFRS-R score (cases only), and selection arising from a case group that 
disproportionately included long-term survivors and a control group that may differ from 
U.S. military veterans at large.
Using these data, we found no difference in the odds of ALS among veterans of the Air 
Force, Army, Marines, and Navy, but higher odds among veterans whose longest 
deployment was WWII or the Korean War and a positive trend with total time of all 
deployments. ALS was more common among veterans who were exposed to specific 
exposures experienced during service or deployment to the four wars, including pesticide-, 
chemical-, and radiation-related exposures. Results were similar in several secondary 
analyses, for example after restricting to cases enrolled within two years of diagnosis, to 
cases who had definite or probable ALS, or to participants who did not require a proxy 
interview.
Several studies have evaluated associations between characteristics of military service and 
ALS. ALS incidence or mortality was positively associated with deployment to the Gulf War 
in five of seven studies (Barth et al., 2009; Coffman et al., 2005; Haley, 2003; Horner et al., 
2008; Horner et al., 2003; Kang and Bullman, 2001; Smith et al., 2000) and not associated 
with service in the Korean War in another (Kurtzke and Beebe, 1980). Service during the 
time of WWII was positively associated with ALS mortality in one study (Weisskopf et al., 
2015), but time period of service was not associated with ALS hospitalization or mortality in 
three others (Bergman et al., 2015; Fang et al., 2009; Seals et al., 2015; Weisskopf et al., 
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2005). Four studies found no association between service branch and ALS incidence or 
mortality (Binazzi et al., 2009; Fang et al., 2009; Kurtzke and Beebe, 1980; Weisskopf et al., 
2005), but a spatial analysis of Gulf War veterans observed significantly lower ALS 
incidence for members of the Marine Corps compared to the Army (Miranda et al., 2008). 
Years of service was not associated with ALS incidence or mortality in three studies 
(Bergman et al., 2015; Fang et al., 2009; Weisskopf et al., 2005), but another study found 
elevated rates of ALS hospitalization with increasing years of service (Seals et al., 2015). 
Highest rank attained was not associated with ALS deaths in another study (Kurtzke and 
Beebe, 1980). To our knowledge, no previous study has evaluated associations between total 
time of all deployments and ALS. In our study, the odds of ALS were higher among veterans 
whose longest deployment was to WWII or the Korean War, had a positive trend with total 
time of all deployments, did not vary across the four major branches, had an inverse trend 
with years of service and end of most recent service, and were lower among officers, 
although this last result attenuated in secondary analyses. Reasons we did not find a positive 
association between ALS and deployment to the Gulf War are unknown, but could be related 
to differences between previous studies and our study in the exposure metric (ever vs. 
longest deployment), choice of comparison group (Gulf War era veterans not deployed or 
deployed elsewhere vs. veterans of all eras not deployed to any war/operation), time period 
of case identification (Horner et al. (Horner et al., 2003) identified cases for the period 
1990–2000, whereas we identified cases from 2005 to 2010), or sample size (Horner et al. 
(Horner et al., 2003) identified 40 deployed cases, whereas we identified 11).
There are at least three possible explanations for the inverse associations we observed 
between ALS and military service and deployment factors. First, our control group may have 
included many longer-serving veterans. For example, we observed significant inverse trends 
between ALS and number of service branches and years of service. The odds of ALS were 
also lower among veterans who had been officers or who had education beyond high school. 
In addition, the odds were lower among veterans whose longest service was in branches 
other than the Air Force, Army, Marines, or Navy; this category included 36 cases and 168 
controls whose longest service branch was National Guard or Reserves. We attempted to 
remove this apparent selection bias through the use of weights, but residual selection bias is 
possible. Second, these inverse associations may have been confounded by years of service, 
which seems likely because many of these associations attenuated when we additionally 
included years of service in models for the confounding weights. Finally, the healthy worker 
survivor effect, which occurs when those who stay in the workforce (i.e., military) over time 
are healthier than those who die or drop out (Arrighi and Hertz-Picciotto, 1994), may have 
contributed to the inverse associations we observed. We are unaware of any statistical 
methods currently available to correct bias from the healthy worker survivor effect in case-
control studies, particularly ones that sampled cases and controls from those available at the 
end of follow-up, as ours did.
We found positive associations between ALS and exposures experienced during service or 
deployment to the four wars: pesticides and related compounds (herbicides in general, Agent 
Orange in particular, pyridostigmine bromide, personal pesticides); certain chemicals 
(exhaust from heaters or generators, burning agents), radiation (nasopharyngeal radium, 
high-intensity radar), and other exposures (anthrax vaccination, contaminated food, 
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explosions within one mile). Several of these findings are consistent with results of general 
population studies and meta-analyses of associations between ALS and exposure to 
pesticides (Kamel et al., 2012; Malek et al., 2012), chemicals or solvents (McGuire et al., 
1997; Pamphlett, 2012), and magnetic fields (i.e., non-ionizing radiation) (Vergara et al., 
2013). These findings also agree with a study of male U.S. Army Chemical Corps veterans 
who were responsible for mixing and applying herbicides (including Agent Orange), riot 
control substances, and burning agents during the Vietnam War. That study found these 
veterans to have a non-significantly elevated rate of mortality from nervous system diseases 
relative to the entire U.S. male population (Thomas and Kang, 1990). A study of Vietnam 
veterans from Korea found a positive association between Agent Orange and self-reported 
ALS when based on a self-reported perceived Agent Orange exposure index (Yi et al., 
2013), but no association when employing two separate geographic information system 
(GIS) models to assess exposure (Yi et al., 2013). Another study of the same population 
reported no association between GIS-based exposure to Agent Orange and ALS identified 
via health insurance claims data (Yi et al., 2014). In our study, the publicity surrounding 
Agent Orange exposure may have led to its being over-reported—more so by cases than 
controls—particularly for those who reported exposure in the field. Therefore, we explored 
the plausibility of veterans’ self-reported Agent Orange exposures and found that 90% 
(cases: 88%; controls: 92%) and 94% (cases: 88%; controls: 99%) of veterans who reported 
mixing and applying or exposure in the field, respectively, reported being in Vietnam during 
the time Agent Orange was used (i.e., 1965–1970) (Institute of Medicine, 1994). In addition, 
excluding individuals with implausible values for these exposures gave slightly attenuated, 
but qualitatively similar, results (not shown). These results should be interpreted cautiously, 
however, because we could not directly validate self-reported Agent Orange exposure.
Our finding of a positive association between ALS and explosions within one mile is 
difficult to interpret. This exposure may have been a marker of lower socioeconomic status 
or rank because veterans who were less educated or non-officers may have been more likely 
to be directly involved in combat and, therefore, exposed to explosions than veterans who 
were more educated or officers. Our data did not support this explanation, however, because 
results were similar when we adjusted for highest degree attained or rank (not shown). 
Explosions within one mile may have been correlated with other combat-related exposures, 
but results were similar when we mutually-adjusted correlated exposures (not shown). 
Furthermore, the largest partial Spearman correlation coefficient between explosions within 
one mile and the other war-specific exposures in our study was only 0.27 (combat-related 
injury). Finally, explosions within one mile could have caused stress or trauma, which may 
be a risk factor for ALS (Pupillo et al., 2012). Our data did not support this explanation, 
however, because veterans who reported any other exposure or experience not asked about 
which they considered harmful or extremely stressful did not have increased odds of ALS 
(OR = 0.81; 95% CI: 0.48, 1.38), although this exposure had substantial missing data. Thus, 
explanations for a positive association between ALS and explosions within one mile are 
unknown.
Reporting errors may explain, at least in part, the positive associations we observed between 
ALS and anthrax vaccination or pyridostigmine bromide if cases were more likely than 
controls to report military service during times these exposures were not encountered. In 
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fact, some veterans who reported these exposures served in the military in the 1950s and 
1960s even though anthrax vaccination was not available until 1998 (Smith et al., 2007a) 
and pyridostigmine bromide was available only during the Gulf War and for combat since 
2003 (U.S. Food and Drug Administration, 2003). Excluding individuals with implausible 
values for these exposures removed the positive associations (anthrax vaccination: OR = 
0.60; 95% CI: 0.22, 1.64; pyridostigmine bromide: OR = 0.49; 95% CI: 0.14, 1.73).
Our findings of no association between smallpox vaccination and ALS, but a borderline 
significant trend for total number of preventive vaccinations, suggests ALS may be 
associated with vaccinations only at high levels of exposure or only for other vaccines. 
Another study, however, reported no association between ALS deaths and immunizations 
during service (Kurtzke and Beebe, 1980). A study found no association between ALS 
mortality and exposure to smoke from oil well fires during deployment to the Gulf War 
(Barth et al., 2009), which agrees with our result.
Associations we observed between ALS and specific exposures experienced during 
deployment to the four wars may have been confounded by other exposures experienced 
during military service or civilian life. We did not adjust analyses for non-military 
exposures, but mutual adjustment for correlated military exposures gave similar results, 
mitigating this concern.
We examined the appropriateness of the weights used in our analysis. Means of truncated 
overall stabilized weights were typically near one and extreme weights were rare (not 
shown). Time-related variables, such as end of most recent service or deployment, were 
usually the exceptions. Cross-tabulations of age and the affected variables showed empty 
cells, particularly in the extreme combinations of age and the variables (not shown), which 
compromise weighted analyses. These empty cells are likely structural rather than random 
(Cole and Hernan, 2008), because, for example, Gulf War veterans were very unlikely to 
have been > 79 years-old when GENEVA was conducted. Collapsing categories of both age 
and the affected variables fixed the problem and gave similar ORs and 95% CIs compared to 
the expanded versions (not shown).
We were only able to weight GENEVA cases to represent Registry cases, so our results do 
not generalize to veteran cases who died before Registry enrollment began in 2003 (Pastula 
et al., 2009) or who did not join the Registry for other reasons. Furthermore, the median 
time from Registry enrollment to GENEVA enrollment was nine (IQR = 11) months, a short 
period compared to elapsed time since diagnosis for long-surviving cases. Additionally, the 
BIRLS sample of potential controls is likely missing a subset of veterans whose release of 
active duty date was before 1973 (Schmidt et al., 2008). The age distribution of the BIRLS 
sample is also different from that of the general veteran population because it was age-
stratified. However, results were similar when we included a stabilized selection weight to 
weight the BIRLS sample to the age distribution of all U.S. military veterans in 2005 using 
data from the American Community Survey (Bureau of the Census, 2012). Nevertheless, 
residual selection bias could have affected our results, particularly because we did not have 
information on education or military rank—two factors inversely associated with ALS in our 
study—for the BIRLS sample.
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Using cases from the Registry to study ALS has inherent limitations. Despite a national 
recruiting effort (Allen et al., 2008), under-ascertainment of cases in the Registry seems 
likely, especially considering the likely under-ascertainment of cases among non-deployed 
veterans in the VA’s previous Gulf War ALS study (Coffman et al., 2005; Horner et al., 
2003). In addition, Registry cases are a mix of incident and long-surviving, prevalent cases 
(Schmidt et al., 2008; Schmidt et al., 2010). Confidence in our results is increased, however, 
because results changed little after we restricted to cases enrolled in GENEVA within two 
years of diagnosis.
Lack of suitable biomarkers and sufficiently detailed military databases for most exposures 
evaluated here necessitated the use of self-report. The validity and reliability of a number of 
self-reported military-related factors have been evaluated by several studies, usually in 
comparison to data from the U.S. Department of Defense’s Defense Manpower Data Center, 
and been characterized as ranging from “moderate” (e.g., κ = 0.41–0.60) to “almost perfect” 
(e.g., κ > 0.80) (Bramsen et al., 2001; Horner et al., 2003; Janes et al., 1991; LeardMann et 
al., 2007; Mahan, 2004; Roemer et al., 1998; Smith et al., 2007a; Smith et al., 2007b; Smith 
et al., 2007c; Southwick et al., 1997). Military-related factors evaluated in validity studies 
included deployment status and frequency, number, and start dates of deployment(s) (Horner 
et al., 2003; Smith et al., 2007b); occupational titles (Smith et al., 2007c); and anthrax 
(LeardMann et al., 2007; Smith et al., 2007a) or smallpox vaccination (Mahan, 2004). 
Reliability studies evaluated combat-related experiences, exposures, or traumatic events 
(Bramsen et al., 2001; Janes et al., 1991; Roemer et al., 1998; Southwick et al., 1997) and 
exposure indices created by summing or averaging participants’ responses for individual 
items (Bramsen et al., 2001; Janes et al., 1991; Roemer et al., 1998; Southwick et al., 1997). 
None of these studies, however, were able to assess the validity or reliability of self-reported 
military-related factors extending back to WWII (the longest time between exposure and 
exposure assessment in these studies was about 10 years (Horner et al., 2003)) or whether 
the quality of self-report varied by war or time period.
In general, we expect military service factors, such as branch of service or rank, to be 
reported more validly and reliably than military deployment factors, such as war/operation 
of deployment or dates of deployment, which would be reported more validly and reliably 
than specific military exposures because this pattern has been observed in other occupational 
epidemiology studies (i.e., job title is reported more validly and reliably than dates of 
employment or job tasks, which are reported more validly and reliably than specific 
occupational exposures) (Teschke et al., 2002). Importantly, there seems to be little evidence 
that cases of various diseases recall past occupational factors and exposures differently than 
controls (Teschke et al., 2002). Furthermore, efforts were made to improve recall in 
GENEVA by: asking participants about exposures that can be sensed (e.g., explosions within 
one mile), using general terms (e.g., flea collar rather than specific pesticides), querying a 
list of specific exposures, and providing benchmarks against which respondents could 
compare their levels of exposure (e.g., feeling ill after exposure) (Schmidt et al., 2008). 
Finally, restricting analyses to non-proxy interviews did not substantively change results.
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5. Conclusions
In this large study that included detailed information on several military-related factors and 
employed sophisticated analytic approaches to minimize bias, the odds of ALS did not differ 
among veterans of the Air Force, Army, Marines, and Navy and were higher among veterans 
whose longest deployment was to WWII or the Korean War. There was also a positive trend 
between ALS and total time of all deployments. ALS was more common among veterans 
who were exposed to specific exposures experienced during service or deployment to the 
four wars—including pesticide-, chemical-, and radiation-related exposures—which are 
similar to those associated with ALS in other studies of military veterans or the general 
population. These results require replication and further study, especially because some of 
them may have been confounded by other exposures experienced during military service or 
civilian life. Nevertheless, these results are potentially important given the large number of 
U.S. military veterans and they provide clues to the potential causal factor(s) underlying the 
apparent increase of ALS in veteran populations.
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Highlights
• We evaluate military factors in relation to amyotrophic lateral sclerosis (ALS).
• We study aspects of service, deployments, and 39 military exposures among 
veterans.
• Veterans of the Air Force, Army, Marines, and Navy had similar odds of ALS.
• Veterans deployed to World War II or the Korean War had elevated odds of ALS.
• Nine pesticide, chemical, radiation, and other exposures increased odds of ALS.
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Figure 1. 
Flow diagram depicting the ascertainment of GENEVA cases. Solid boxes or lines represent 
cases who advanced past each step shown. Small-dashed boxes or lines represent cases who 
were excluded after each step shown, but who were incorporated into the analysis via inverse 
probability weights (see Section 2.3 and Supplementary data, p. S6, for more details). 
Reasons cases were ineligible for GENEVA included dementia (n = 9), diagnosis change (n 
= 2), withdrawal from the Registry DNA bank (n = 3), or interview infeasibility (n = 11). 
Abbreviations: ALS, amyotrophic lateral sclerosis; GENEVA, Genes and Environmental 
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Exposures in Veterans with Amyotrophic Lateral Sclerosis study; PLS, primary lateral 
sclerosis.
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Figure 2. 
Flow diagram depicting the ascertainment of GENEVA controls. Solid boxes or lines 
represent potential controls who advanced past each step shown. Small-dashed boxes or 
lines represent potential controls who were excluded after each step shown, but who were 
incorporated into the analysis via inverse probability weights (see Section 2.3 and 
Supplementary data, p. S6, for more details). Reasons potential controls were ineligible for 
GENEVA included not being a U.S. military veteran (n = 13), ALS or other neurological 
disease diagnosis (Schmidt et al., 2008) (n = 32), or other reasons (n = 46). Abbreviations: 
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GENEVA, Genes and Environmental Exposures in Veterans with Amyotrophic Lateral 
Sclerosis study.
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Table 2
Clinical characteristics of amyotrophic lateral sclerosis cases in GENEVA.
Characteristic No. %
Most recent ALS diagnosis category
  Clinically definite 148 24
  Clinically probable 314 51
  Clinically possible 48 8
  Suspected (progressive bulbar palsy or progressive muscular atrophy) 111 18
Symptom onset site
  Bulbar 89 14
  Extremities 500 81
  Othera 31 5
  Missing 1
Time from symptom onset to diagnosis (months)
  ≤ 6 117 19
  > 6–12 168 28
  > 12–18 102 17
  > 18–24 46 8
  > 24 170 28
  Missing 18
  Median ± IQR 13 ± 18
Time from diagnosis to enrollment in the Registry (months)
  ≤ 12 218 35
  > 12–24 142 23
  > 24–36 73 12
  > 36–48 43 7
  > 48 139 23
  Missing 6
  Median ± IQR 18 ± 32
Time from enrollment in the Registry to enrollment in GENEVA (months)
  ≤ 6 180 29
  > 6–12 205 33
  > 12–18 97 16
  > 18–24 74 12
  > 24 65 10
  Median ± IQR 9 ± 11
Baselineb ALSFRS-R score (possible range: 0–48)c
  ≤ 16 135 22
  > 16–23 118 19
  > 23–30 137 22
  > 30–35 110 18
  > 35 121 19
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Characteristic No. %
  Median ± IQR 27 ± 16
Currently using riluzole (baselineb)
  No 301 50
  Yes 304 50
  Missing 16
Abbreviations: ALS, amyotrophic lateral sclerosis; ALSFRS-R, ALS Functional Rating Scale-Revised; GENEVA, Genes and Environmental 
Exposures in Veterans with Amyotrophic Lateral Sclerosis; IQR, interquartile range.
a
Includes “all over” (n < 5d), “cramps/fasciculations” (n = 26), and “loss of appetite” (n < 5d).
b
The ALSFRS-R score or use status of riluzole that was measured closest to the time of GENEVA enrollment (i.e., interview).
cCategory boundaries were set at quintiles of the ALSFRS-R score among all cases.
dSuppressed to preserve the confidentiality of study participants.
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